Institution scientifique

ViiV Healthcare (Spain)

Madrid · ES · company

707Publications signalées

16441Citations signalées

12Thèmes principaux

Principaux domaines

HIV/AIDS drug development and treatmentHIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHIV Research and TreatmentHIV, Drug Use, Sexual RiskResearch Data Management PracticesHepatitis C virus researchScientific Computing and Data ManagementPneumocystis jirovecii pneumonia detection and treatmentAdolescent Sexual and Reproductive HealthHelicobacter pylori-related gastroenterology studiesDiabetes, Cardiovascular Risks, and Lipoproteins

Évolution annuelle

18541

19912

19942

19952

19973

19992

20012

20024

20032

20053

20062

20082

20092

20107

20116

20127

201310

20149

201521

201616

201720

201822

201934

202041

202141

202245

202349

202459

202594

202685

Publications récentes

2026 article

Low Vascular Density at the Pancreatic Resection Margin as a Predictor of Post-Operative Acute Pancreatitis After Pancreatoduodenectomy

Venkatesh Balaraman Sundararajan, Ragini Kilambi, Chhagan Bihari, Senthil Kumar et autres

0 citationsIndian Journal of Surgery

Accès ouvert 2026 preprint

Frontier vision-language models have overtaken young adults at detecting AI-generated portraits -- but not their calibration

Sunwhi Kim, S. M. Kim, Meounggun Jo, Jini Tae

0 citationsarXiv (Cornell University)

Accès ouvert 2026 article

ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine

Daniela Eassey, Jason J. Ong, Ken Koh, David Nolan et autres

0 citationsSexual Health

Accès ouvert 2026 article

Clinical outcomes of a digitally delivered structured lifestyle program in type 2 diabetes: a randomized controlled trial from India

Chhavi Mehra, Annie Mattilda Raymond, Banshi Saboo, Aravinda Jagadeesha et autres

0 citationsFrontiers in Endocrinology

Accès ouvert 2026 article

Similar Efficacy, Safety, and Immune Improvement Through 96 Weeks in Individuals With Limited HIV-1 Treatment Options Using Twice-Daily Dolutegravir- or Fostemsavir-based Regimens

Antonella Castagna, Iacopo Marcon, Fangfang Du, Bo Li et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2026 article

Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modeling

George Bray, Natalya Danchenko, Simon Brassel, Matthew Napier et autres

0 citationsJournal of Medical Economics

Accès ouvert 2026 article

Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL Study

Patrick Philibert, Charlotte Charpentier, Nilakshani Naguleswaran, Caroline Philippe et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2026 article

Design and methods of the “Understanding pre-exposure prophylaxis modalities for HIV prevention in European communities” (PROTECT) survey - exploring the sexual health of men who have sex with men, trans and non-binary people

Johann Kolstee, Haoyi Wang, Hanne Zimmermann, Melanie Schroeder et autres

0 citationsHeliyon

2026 article

Broad reactivity of HLA-E restricted TCRs highlights challenges in universal T cell therapy development 2335164

Chelston Ang, Simon Ellington, Ruhi Roy, María Abad-Fernández et autres

0 citationsThe Journal of Immunology

Accès ouvert 2026 article

VOGUE: Noninferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to Treatment

Jade Ghosn, Federico Pulido, Gustavo Lopardo, Anita Olczak et autres

0 citationsOpen Forum Infectious Diseases

Accès ouvert 2026 review

The burden of HIV-related stigma on clinical and quality of life outcomes: results from a systematic literature review

Irina Kolobova, Natalya Danchenko, I. Jacob, Dennis Rice et autres

0 citationsHealth Psychology and Behavioral Medicine

Accès ouvert 2026 article

Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover Study

Emilie R Elliot, Justine Boles, Dainielle Fox, Katherine Nelson et autres

0 citationsAdvances in Therapy

Site officiel Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.